Purpose Driven Research

Genetic Disease Investigators LLC,  Diana Driscoll, OD, President, is a global leader in autonomic research. The first to identify abnormalities of parasympathetic nerves (such as the vagus nerve), vascular problems, and intracranial pressure abnormalities, Genetic Disease Investigators LLC continues to release answers —  years in advance of others.

Help us get answers! Sign up for a study today!

If you are a chronic dry eye patient interested in new treatments, we invite you to participate in these studies:

Dry Eye Survey:

Complete this 3-minute survey to see if your dry eyes could be more than just an “eye problem”.

Dry Eye Treatment Study

This exciting new study will be treating dry eyes using NeuroTears./span> This ground-breaking research uses a patented over-the-counter supplement to stimulate both inflammation control and tear production simultaneously. Please let us know if you are interested and we will reach out to you to see if you qualify.

Let us know if you’re interested!

Latest Research
The Future of Medicine Today

COVID and the Vagus Nerve – An amazing discovery

The vagus nerve is affected in post-COVID Longhaulers! This contributes to dysautonomia (dysfunction of parts of the autonomic nervous system)

Do you need to stimulate your vagus nerve?

The vagus nerve is the major nerve controlling the parasympathetic nervous system – the system of the body that allows us to

Vascular fundus changes in patients with high probability of chronic cerebrospinal venous insufficiency

Presented February 2012- International Society of Neurovascular Disease. This study included co-authors Dr. Clair Francomano and Diana Driscoll, OD and involved the evaluation of 60 fundus images of patients with EDS/POTS or multiple sclerosis, as compared to…

Acetazolomide as a medical treatment option for patients with neurodegenerative disease

Cardiac effects in the multiple sclerosis patient

Vascular fundus changes in patients with high probability of chronic cerebrospinal venous insufficiency

Head circumference growth in children with Ehlers-Danlos syndrome who developed dysautonomia later in life

Inflammatory cytokines in patients with EDS / POTS / Dysautonomia

Evaluation of lipo(a) in patients with vascular fibrosis and EDS/POTS/Dysautonomia

Evaluation of potential IIHWOP in patients with EDS/POTS/Dysautonomia and treatments with acetazolamide, if indicated